| Company Name | Beactica Therapeutics UK Limited |
|---|---|
| Director | Per Kallblad |
| Company Status | Active |
| Company Number | SC726725 |
| Category | Private Limited Company |
| Incorporation Date | 18 March 2022(2 years, 1 month ago) |
Business Activity
| Section M | Professional, scientific and technical activities |
|---|---|
| SIC 7310 | R & D on nat sciences & engineering |
| SIC 72190 | Other research and experimental development on natural sciences and engineering |
Director
| Director Name | Dr Per Kallblad |
|---|---|
| Date of Birth | November 1968 (Born 55 years ago) |
| Nationality | Swedish |
| Status | Current |
| Appointed | 18 March 2022(same day as company formation) |
| Role | Company Director |
| Country of Residence | Scotland |
| Correspondence Address | C/O Eq Accountants Limited Pentland House Saltire Centre Glenrothes Fife KY6 2AH Scotland |
Location
| Registered Address | C/O Eq Accountants Limited Pentland House Saltire Centre Glenrothes Fife KY6 2AH Scotland |
|---|---|
| Constituency | Glenrothes |
| Ward | Glenrothes West and Kinglassie |
| Address Matches | 2 other UK companies use this postal address |
Accounts
| Latest Accounts | 31 December 2022 (1 year, 3 months ago) |
|---|---|
| Next Accounts Due | 30 September 2024 (5 months, 1 week from now) |
| Accounts Category | Total Exemption Full |
| Accounts Year End | 31 December |
Returns
| Latest Return | 17 March 2024 (1 month ago) |
|---|---|
| Next Return Due | 31 March 2025 (11 months, 2 weeks from now) |
Filing History
| 4 April 2023 | Total exemption full accounts made up to 31 December 2022 (8 pages) |
|---|---|
| 21 March 2023 | Confirmation statement made on 17 March 2023 with no updates (3 pages) |
| 20 March 2023 | Previous accounting period shortened from 31 March 2023 to 31 December 2022 (1 page) |
| 18 March 2022 | Incorporation Statement of capital on 2022-03-18
|